Czech National Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Buy
163,895
+5,853
+4% +$490K 0.08% 224
2026
Q1
$12.7M Buy
158,042
+5,025
+3% +$414K 0.08% 219
2025
Q4
$13M Buy
153,017
+3,905
+3% +$320K 0.08% 204
2025
Q3
$11.6M Buy
149,112
+5,727
+4% +$447K 0.08% 219
2025
Q2
$11.2M Buy
143,385
+7,917
+6% +$590K 0.09% 205
2025
Q1
$9.82M Buy
135,468
+7,587
+6% +$543K 0.09% 215
2024
Q4
$9.47M Buy
127,881
+5,166
+4% +$362K 0.09% 205
2024
Q3
$8.1M Buy
122,715
+7,883
+7% +$573K 0.08% 230
2024
Q2
$10.6M Buy
114,832
+8,118
+8% +$719K 0.12% 159
2024
Q1
$10.2M Buy
106,714
+489
+0.5% +$41.1K 0.13% 157
2023
Q4
$8.1M Sell
106,225
-27
-0% -$1.88K 0.12% 177
2023
Q3
$7.36M Buy
106,252
+34,487
+48% +$2.77M 0.12% 171
2023
Q2
$6.77M Sell
71,765
-1,070
-1% -$93K 0.15% 134
2023
Q1
$6.03M Buy
72,835
+462
+0.6% +$36.3K 0.15% 137
2022
Q4
$5.4M Buy
72,373
+327
+0.5% +$25.2K 0.14% 155
2022
Q3
$5.95M Buy
+72,046
New +$6.93M 0.17% 127

Other funds holding EW

Czech National Bank's EW Position: Q2 2026 in Review

Czech National Bank increased its Edwards Lifesciences (EW) stake by 3.7% in Q2 2026, buying an estimated $490K and bringing the position to 163,895 shares worth $14.8M. The position accounts for 0.08% of the portfolio, ranked #224.

Czech National Bank first reported a position in EW in Q3 2022 and has held it in 16 quarters since. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Czech National Bank held 163,895 shares of Edwards Lifesciences worth $14.8M as of Q2 2026.
  • Czech National Bank bought 5,853 Edwards Lifesciences shares in Q2 2026, an estimated $490K.
  • Edwards Lifesciences made up 0.08% of Czech National Bank's portfolio in Q2 2026, its #224 holding.
  • Czech National Bank first reported a position in Edwards Lifesciences in Q3 2022 and has held it in 16 quarters since.
  • 458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.